Inogen (INGN) Cost of Revenue (2013 - 2026)

Inogen (INGN) has 14 years of Cost of Revenue data on file, last reported at $47.2 million in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 2.91% year-over-year to $47.2 million in Q1 2026; TTM through Mar 2026 was $195.7 million, a 6.84% increase from a year earlier, with the FY2025 full-year figure at $194.4 million, up 7.43% from the prior year.
• Cost of Revenue for Q1 2026 stood at $47.2 million, up from $46.5 million in the prior quarter.
• Over the last five years, Cost of Revenue for INGN reached as high as $62.6 million in Q3 2022 and fell as low as $41.4 million in Q1 2023.
• Historically, Cost of Revenue has averaged $49.1 million across 5 years, with a median of $47.5 million in 2024.
• Across the five-year window, Cost of Revenue surged 55.02% in 2022 and decreased 19.79% in 2023, its largest moves.
• Year by year, Cost of Revenue stood at $58.6 million in 2022, then retreated by 18.56% to $47.7 million in 2023, then slipped by 8.27% to $43.8 million in 2024, then rose by 6.15% to $46.5 million in 2025, then rose by 1.64% to $47.2 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $47.2 million in Q1 2026, $46.5 million in Q4 2025, and $51.1 million in Q3 2025.